SIGNA™ Sprint is an AI-enabled medical device from GE Medical Systems, LLC, listed by FDA (510(k), K251399) with a decision date of 2025-09-11. Review panel: Radiology.
| FDA submission number | K251399 |
|---|---|
| Pathway | 510(k) |
| Company | GE Medical Systems, LLC |
| Review panel (specialty) | Radiology |
| FDA decision date | 2025-09-11 |
| Decision | Substantially Equivalent |
| Product code | LNH |
| Classification | System, Nuclear Magnetic Resonance Imaging |
| Device class | 2 |
| Regulation number | 892.1000 |
| Review time (calendar days) | 128 |
| Applicant country | US |
Official FDA database record · FDA AI-enabled device list
More devices from GE Medical Systems, LLC · All Radiology AI devices · Full device index
Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.